Clinical performance targets and quality of life in hemodialysis patients

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 73-79

  Mazairac, Albert H A ^a   De Wit, G Ardine ^a,b   Grooteman, Muriel P C ^c   Penne, E Lars ^a,c   Van Der Weerd, Neelke C ^a,c   Den Hoedt, Claire H ^a,d   Lévesque, Renée ^e   Van Den Dorpel, Marinus A ^d   Nubé, Menso J ^c   Ter Wee, Piet M ^c   Blankestijn, Peter J ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Maasstad Hospital Rotterdam   (Netherlands)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Clinical performance targets; Hemodialysis; Quality of life; Risk factors

Indexed keywords

HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS; UREA;

ADULT; ARTICLE; BLOOD PRESSURE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SURVIVAL; VASCULAR ACCESS; VENTRICULOATRIAL SHUNT;

AGED; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PHOSPHORUS; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 84855161362     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000334639     Document Type: Article

References (32)

1. Testa MA, Simonson DC: Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840.
2. Mittal SK, Ahern L, Flaster E, Maesaka JK, Fishbane S: Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1387-1394.
3. Schwartz A, Hazen GB, Leifer A, Heckerling PS: Development of goal-sensitive health-related utility assessment procedures. Med Decis Mak ing 2009; 29: 590-598.
4. Rocco MV, Berns JS: KDOQI in the era of global guidelines. Am J Kidney Dis 2009; 54: 781-787.
5. Plantinga LC, Fink NE, Jaar BG, Sadler JH, Levin NW, Coresh J, Klag MJ, Powe NR: Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res 2007; 7: 5.
6. Slinin Y, Guo H, Gilbertson DT, Mau LW, Ensrud K, Rector T, Collins AJ, Ishani A: Meeting KDOQI guideline goals at hemodi-alysis initiation and survival during the first year. Clin J Am Soc Nephrol 2010; 5:1574-1581.
7. Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG: Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol 2007; 18: 2377-2384.
8. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, van der Tweel I, Ter Wee PM: Effect of increased convective clearance by on-line hemodiafil-tration on all cause and cardiovascular mortality in chronic hemodialysis patients-the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 2005; 6: 8.
9. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4:1205-1213.
10. Fouque D, Vennegoor M, ter WP, Wanner C, Basci A, Canaud B, Haage P, Konner K, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Tordoir J, Vanholder R: EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22(suppl 2):ii45-ii87.
11. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48(suppl 1):S2-S90.
12. KDOQI Clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530.
13. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(suppl 1): S176-S247.
14. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42:S1-S201.
15. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43:S1-S290.
16. Agarwal R, Peixoto AJ, Santos SF, Zoccali C: Pre-and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398.
17. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB: Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res 1994; 3:329-338.
18. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT: Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res 2002; 11: 437-447.
19. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey-Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993.
20. Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User's Manual, ed 2. Boston, The Health Institute, New England Medical Center, 1994.
21. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
22. Hochberg Y, Benjamini Y: More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811-818.
23. Donders AR, van der Heijden GJ, Stijnen T, Moons KG: Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-1091.
24. Leinau L, Murphy TE, Bradley E, Fried T: Relationship between conditions addressed by hemodialysis guidelines and non-ESRD-specific conditions affecting quality of life. Clin J Am Soc Nephrol 2009; 4:572-578.
25. Lacson E Jr, Wang W, Lazarus JM, Hakim RM: Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes. Am J Kidney Dis 2009; 54:490-497.
26. Lopes AA, Bragg-Gresham JL, Goodkin DA, Fukuhara S, Mapes DL, Young EW, Gillespie BW, Akizawa T, Greenwood RN, Andreucci VE, Akiba T, Held PJ, Port FK: Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res 2007; 16:545-557.
27. Wasse H, Kutner N, Zhang R, Huang Y: Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol 2007; 2:708-714.
28. Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ: The impact of selecting a hig h he mog lobi n t a rget le ve l on hea lt h-relat-ed quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med 2009; 169: 1104-1112.
29. Merkus MP, Jager KJ, Dekker FW, Boes-choten EW, Stevens P, Krediet RT: Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The NECOSAD Study Group. Am J Kidney Dis 1997; 29: 584-592.
30. Plantinga LC, Fink NE, Harrington-Levey R, Finkelstein FO, Hebah N, Powe NR, Jaar BG: Association of social support with outcomes in incident dialysis patients. Clin J Am Soc Nephrol 2010; 5:1480-1488.
31. Untas A, Thumma J, Rascle N, Rayner H, Mapes D, Lopes AA, Fukuhara S, Akizawa T, Morgenstern H, Robinson BM, Pisoni RL, Combe C: The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol 2011; 6:142-152.
32. Mazairac AH, de Wit GA, Penne EL, van der Weerd NC, Grooteman MP, van den Dorpel MA, Nube MJ, Buskens E, Levesque R, Ter Wee PM, Bots ML, Blankestijn PJ: Protein-energy nutritional status and kidney disease-specific quality of life in hemodialysis patients. J Ren Nut r 2011; 21: 376-386.